Redox signaling in drug-tolerant persister cells as an emerging therapeutic target

Z Zhang, Y Tan, C Huang, X Wei - EBioMedicine, 2023 - thelancet.com
Drug-tolerant persister (DTP) cells have attracted significant interest, given their
predominant role in treatment failure. In this respect, DTP cells reportedly survive after …

Cancer stem cells and their niche in cancer progression and therapy

Q Liu, Z Guo, G Li, Y Zhang, X Liu, B Li, J Wang… - Cancer Cell …, 2023 - Springer
High recurrence and metastasis rates and poor prognoses are the major challenges of
current cancer therapy. Mounting evidence suggests that cancer stem cells (CSCs) play an …

BMS-986158, a small molecule inhibitor of the bromodomain and extraterminal domain proteins, in patients with selected advanced solid tumors: results from a phase …

J Hilton, M Cristea, S Postel-Vinay, C Baldini… - Cancers, 2022 - mdpi.com
Simple Summary Bromodomain and extraterminal domain (BET) proteins can regulate
cancer-related genes to make tumors grow. BMS-986158, an experimental anticancer …

Natural products as drug candidates for breast cancer

NT Telang - Oncology Letters, 2023 - spandidos-publications.com
Progression of early‑stage breast cancer to advanced‑stage metastatic disease represents a
major cause of death in women. Long‑term conventional and targeted therapy for breast …

UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb

Y Guo, X Chen, X Zhang, X Hu - Frontiers in Oncology, 2023 - frontiersin.org
Purpose Ubiquitin-conjugating enzymes E2S (UBE2S) and E2C (UBE2C), which mediate
the biological process of ubiquitination, have been widely reported in various cancers …

Loss of NSUN6 inhibits osteosarcoma progression by downregulating EEF1A2 expression and activation of Akt/mTOR signaling pathway via m5C methylation

S Hu, M Yang, K Xiao, Z Yang… - Experimental and …, 2023 - spandidos-publications.com
As an important 5‑methylcytidine (m 5 C) methyltransferase, NOP2/Sun RNA
methyltransferase family member 6 (NSUN6) has been reported to play an important role in …

Role of vitamin C in targeting cancer stem cells and cellular plasticity

Y Lee - Cancers, 2023 - mdpi.com
Simple Summary This review is centered on the potential therapeutic utility of vitamin C (VC)
in the context of dynamic cancer evolution. Physiologically, VC has dose-dependent roles as …

Self-renewal and pluripotency in osteosarcoma stem cells' chemoresistance: notch, hedgehog, and Wnt/β-Catenin interplay with embryonic markers

SR Martins-Neves, G Sampaio-Ribeiro… - International journal of …, 2023 - mdpi.com
Osteosarcoma is a highly malignant bone tumor derived from mesenchymal cells that
contains self-renewing cancer stem cells (CSCs), which are responsible for tumor …

Cancer cell plasticity, stem cell factors, and therapy resistance: how are they linked?

H Fatma, HR Siddique - Cancer and Metastasis Reviews, 2024 - Springer
Cellular plasticity can occur naturally in an organism and is considered an adapting
mechanism during the developmental stage. However, abnormal cellular plasticity is …

Update on the molecular pathology of cutaneous squamous cell carcinoma

EC Cozma, LM Banciu, C Soare… - International Journal of …, 2023 - mdpi.com
Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer,
originating from keratinocytes of the spinous layer. Numerous risk factors have been …